These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 30553758)
1. Efficacy and safety of lipoprotein apheresis in children with homozygous familial hypercholesterolemia: A systematic review. Luirink IK; Determeijer J; Hutten BA; Wiegman A; Bruckert E; Schmitt CP; Groothoff JW J Clin Lipidol; 2019; 13(1):31-39. PubMed ID: 30553758 [TBL] [Abstract][Full Text] [Related]
2. Homozygous familial hypercholesterolemia with severe involvement of the aortic valve-A sibling-controlled case study on the efficacy of lipoprotein apheresis. Galiano M; Hammersen J; Sauerstein K; Blessing H; Rümmele P; Purbojo A; Schöber M; Moosmann J; Raffelsbauer G; Heibges A; Klingel R J Clin Apher; 2020 Jun; 35(3):163-171. PubMed ID: 32163632 [TBL] [Abstract][Full Text] [Related]
3. Practice of lipoprotein apheresis and short-term efficacy in children with homozygous familial hypercholesterolemia: Data from an international registry. Luirink IK; Hutten BA; Greber-Platzer S; Kolovou GD; Dann EJ; de Ferranti SD; Taylan C; Bruckert E; Saheb S; Oh J; Driemeyer J; Farnier M; Pape L; Schmitt CP; Novoa FJ; Maeser M; Masana L; Shahrani A; Wiegman A; Groothoff JW Atherosclerosis; 2020 Apr; 299():24-31. PubMed ID: 32199148 [TBL] [Abstract][Full Text] [Related]
4. Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia-target attainment requires further increase of intensity. Klaus G; Taylan C; Büscher R; Schmitt CP; Pape L; Oh J; Driemeyer J; Galiano M; König J; Schürfeld C; Spitthöver R; Schaefer JR; Weber LT; Heibges A; Klingel R Pediatr Nephrol; 2018 Jul; 33(7):1199-1208. PubMed ID: 29502162 [TBL] [Abstract][Full Text] [Related]
5. Cardiovascular outcomes in patients with homozygous familial hypercholesterolaemia on lipoprotein apheresis initiated during childhood: long-term follow-up of an international cohort from two registries. Reijman MD; Tromp TR; Hutten BA; Hovingh GK; Blom DJ; Catapano AL; Cuchel M; Dann EJ; Gallo A; Hudgins LC; Raal FJ; Ray KK; Sadiq F; Soran H; Groothoff JW; Wiegman A; Kusters DM; ; Lancet Child Adolesc Health; 2024 Jul; 8(7):491-499. PubMed ID: 38759658 [TBL] [Abstract][Full Text] [Related]
6. High serum triglyceride concentrations in patients with homozygous familial hypercholesterolemia attenuate the efficacy of lipoprotein apheresis by dextran sulfate adsorption. Drouin-Chartier JP; Tremblay AJ; Bergeron J; Lamarche B; Couture P Atherosclerosis; 2018 Mar; 270():26-32. PubMed ID: 29407885 [TBL] [Abstract][Full Text] [Related]
7. Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey. D'Erasmo L; Gallo A; Cefalù AB; Di Costanzo A; Saheb S; Giammanco A; Averna M; Buonaiuto A; Iannuzzo G; Fortunato G; Puja A; Montalcini T; Pavanello C; Calabresi L; Vigna GB; Bucci M; Bonomo K; Nota F; Sampietro T; Sbrana F; Suppressa P; Sabbà C; Fimiani F; Cesaro A; Calabrò P; Palmisano S; D'Addato S; Pisciotta L; Bertolini S; Bittar R; Kalmykova O; Béliard S; Carrié A; Arca M; Bruckert E Orphanet J Rare Dis; 2021 Sep; 16(1):381. PubMed ID: 34496902 [TBL] [Abstract][Full Text] [Related]
8. A cross-national investigation of cardiovascular survival in homozygous familial hypercholesterolemia: The Sino-Roman Study. Stefanutti C; Pang J; Di Giacomo S; Wu X; Wang X; Morozzi C; Watts GF; Lin J J Clin Lipidol; 2019; 13(4):608-617. PubMed ID: 31255589 [TBL] [Abstract][Full Text] [Related]
9. A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry). Kayikcioglu M; Tokgozoglu L; Yilmaz M; Kaynar L; Aktan M; Durmuş RB; Gokce C; Temizhan A; Ozcebe OI; Akyol TK; Okutan H; Sag S; Gul OO; Salcioglu Z; Yenercag M; Altunkeser BB; Kuku I; Yasar HY; Kurtoglu E; Kose MD; Demircioglu S; Pekkolay Z; Ilhan O Atherosclerosis; 2018 Mar; 270():42-48. PubMed ID: 29407887 [TBL] [Abstract][Full Text] [Related]
10. Management of homozygous familial hypercholesterolemia in real-world clinical practice: A report of 7 Italian patients treated in Rome with lomitapide and lipoprotein apheresis. Stefanutti C; Morozzi C; Di Giacomo S; Sovrano B; Mesce D; Grossi A J Clin Lipidol; 2016; 10(4):782-789. PubMed ID: 27578108 [TBL] [Abstract][Full Text] [Related]
11. Lipoprotein apheresis is essential for managing pregnancies in patients with homozygous familial hypercholesterolemia: Seven case series and discussion. Ogura M; Makino H; Kamiya C; Yoshimatsu J; Soran H; Eatough R; Perrone G; Harada-Shiba M; Stefanutti C Atherosclerosis; 2016 Nov; 254():179-183. PubMed ID: 27755983 [TBL] [Abstract][Full Text] [Related]
12. Comparison of two low-density lipoprotein apheresis systems in patients with homozygous familial hypercholesterolemia. Drouin-Chartier JP; Tremblay AJ; Bergeron J; Pelletier M; Laflamme N; Lamarche B; Couture P J Clin Apher; 2016 Aug; 31(4):359-67. PubMed ID: 26011648 [TBL] [Abstract][Full Text] [Related]
14. Vascular access for lipid apheresis: a challenge in young children with homozygous familial hypercholesterolemia. Lischka J; Arbeiter K; de Gier C; Willfort-Ehringer A; Walleczek NK; Gellai R; Boehm M; Wiegman A; Greber-Platzer S BMC Pediatr; 2022 Mar; 22(1):131. PubMed ID: 35279116 [TBL] [Abstract][Full Text] [Related]
15. Lipoprotein apheresis in the management of severe hypercholesterolemia and hyperlipoproteinemia(a)-The Portuguese experience. Ferreira L; Palma I; Bacelar C; Queirós JA; Madureira A; Oliveira JC; Ramos MH; Cardoso H Transfus Apher Sci; 2018 Oct; 57(5):676-680. PubMed ID: 30287070 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of Rosuvastatin in Children With Homozygous Familial Hypercholesterolemia and Association With Underlying Genetic Mutations. Stein EA; Dann EJ; Wiegman A; Skovby F; Gaudet D; Sokal E; Charng MJ; Mohamed M; Luirink I; Raichlen JS; Sundén M; Carlsson SC; Raal FJ; Kastelein JJP J Am Coll Cardiol; 2017 Aug; 70(9):1162-1170. PubMed ID: 28838366 [TBL] [Abstract][Full Text] [Related]
17. Three different schedules of low-density lipoprotein apheresis compared with plasmapheresis in patients with homozygous familial hypercholesterolemia. Berger GM; Firth JC; Jacobs P; Wood L; Marais AD; Horak A Am J Med; 1990 Feb; 88(2):94-100. PubMed ID: 2105647 [TBL] [Abstract][Full Text] [Related]
18. Lipoprotein apheresis efficacy, challenges and outcomes: A descriptive analysis from the UK Lipoprotein Apheresis Registry, 1989-2017. Pottle A; Thompson G; Barbir M; Bayly G; Cegla J; Cramb R; Dawson T; Eatough R; Kale V; Neuwirth C; Nicholson K; Payne J; Scott J; Soran H; Walji S; Watkins S; Weedon H; Nath Datta DB Atherosclerosis; 2019 Nov; 290():44-51. PubMed ID: 31563836 [TBL] [Abstract][Full Text] [Related]
19. Low-density lipoprotein apheresis as long-term treatment for children with homozygous familial hypercholesterolemia. Zwiener RJ; Uauy R; Petruska ML; Huet BA J Pediatr; 1995 May; 126(5 Pt 1):728-35. PubMed ID: 7751996 [TBL] [Abstract][Full Text] [Related]
20. Clinical management, psychosocial characteristics, and quality of life in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis in Turkey: Results of a nationwide survey (A-HIT1 registry). Kayikcioglu M; Kuman-Tunçel O; Pirildar S; Yílmaz M; Kaynar L; Aktan M; Durmuş RB; Gökçe C; Temizhan A; Özcebe OI; Akyol TK; Okutan H; Sağ S; Oz Gul O; Salcioglu Z; Yenercag M; Altunkeser BB; Kuku I; Yasar HY; Kurtoğlu E; Demir M; Demircioğlu S; Pekkolay Z; Ílhan O; Tokgozoglu L J Clin Lipidol; 2019; 13(3):455-467. PubMed ID: 30928440 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]